Back in the thirties we were told we must collectivize the nation because the people were so poor. Now we are told we must collectivize the nation because the people are so rich.”? William F. Buckley Jr.
Today, we revisit a 'Tier 3' biotech stock whose stock has been under some recent pressure. However, it has two potential significant catalysts on the horizon. We update our investment case on this intriguing small-cap concern in the paragraphs below.
Company Overview:
Omeros Corporation (OMER) is a Seattle based commercial-stage biopharmaceutical concern focused